We updated the design of this site on September 25th. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

Insulin Resistance Atherosclerosis Study (IRAS)

This study has been completed.
Sponsor:
ClinicalTrials.gov Identifier:
NCT00005135
First Posted: May 26, 2000
Last Update Posted: August 8, 2016
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Information provided by:
National Heart, Lung, and Blood Institute (NHLBI)
  Purpose
To conduct a multicenter study of the relationship between insulin resistance and cardiovascular disease (CVD) and its risk factors in a tri-ethnic (African-American, Hispanic, and non-Hispanic white) population aged 40 to 69 years at baseline. Also, to identify the genetic determinants of insulin resistance and visceral adiposity.

Condition
Cardiovascular Diseases Atherosclerosis Diabetes Mellitus Heart Diseases Obesity Insulin Resistance

Study Type: Observational

Further study details as provided by National Heart, Lung, and Blood Institute (NHLBI):

Study Start Date: September 1991
Study Completion Date: December 2008
Primary Completion Date: December 2008 (Final data collection date for primary outcome measure)
  Show Detailed Description

  Eligibility

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   up to 100 Years   (Child, Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Criteria
No eligibility criteria
  Contacts and Locations
Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00005135


Sponsors and Collaborators
National Heart, Lung, and Blood Institute (NHLBI)
Investigators
OverallOfficial: Richard Bergman University of Southern California
OverallOfficial: Donald Bowden Wake Forest University
OverallOfficial: Michael Bryer-Ash University of California, Los Angeles
OverallOfficial: Steven Haffner University of Texas
OverallOfficial: Jill Norris University of Colorado, Denver
OverallOfficial: Marian Rewers University of Colorado Health Science Center
OverallOfficial: Mohammed Saad University of Southern California
OverallOfficial: Joseph Selby Kaiser Foundation Research Institute
OverallOfficial: Lynne Wagenknecht Wake Forest University
  More Information

Publications:

ClinicalTrials.gov Identifier: NCT00005135     History of Changes
Other Study ID Numbers: 1005
U01HL047890 ( U.S. NIH Grant/Contract )
First Submitted: May 25, 2000
First Posted: May 26, 2000
Last Update Posted: August 8, 2016
Last Verified: April 2009

Additional relevant MeSH terms:
Diabetes Mellitus
Cardiovascular Diseases
Heart Diseases
Insulin Resistance
Atherosclerosis
Glucose Metabolism Disorders
Metabolic Diseases
Endocrine System Diseases
Hyperinsulinism
Arteriosclerosis
Arterial Occlusive Diseases
Vascular Diseases